Platelet-Rich Plasma-Derived Growth Factor vs Hyaluronic Acid Injection in the Individuals with Knee Osteoarthritis: A One Year Randomized Clinical Trial
Open Access
- 1 July 2020
- journal article
- research article
- Published by Taylor & Francis in Journal of Pain Research
- Vol. ume 13, 1699-1711
Abstract
Objective: In this study, we aimed at performing a comparison between intra-articular injections of PRP-derived growth factor (PGRF) and hyaluronic acid regarding their effect on pain and patient’s function in knee osteoarthritis, as well as their safety profiles. Methods: During our single-masked randomized clinical trial, the candidates with symptomatic knee osteoarthritis received two intra-articular injections of PRGF with 3 weeks apart or received three weekly injections of HA. The mean improvements from before treatment until the second, sixth, and twelfth months post-intervention in scores obtained by visual analog scale (VAS), Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), and Lequesne index were our primary outcomes. Results: A total of 102 candidates were finally included in the study. Patients’ mean age was 57.08± 7.3 years old in the PRGF group compared to the mean age of 58.63± 7.09 years old in HA patients. In the PRGF group, total WOMAC index decreased from 41.96± 11.71 to 27.10± 12.3 (P = 0.02), and from 39.71± 10.4 to 32.41± 11.8 in the HA group after 12 months (P > 0.05). Regarding the Lequesne index, pain, ADL, and global scores significantly decreased after 12 months in the PRGF group compared to the HA group (P< 0.001). There was also a meaningful higher rate of satisfaction in the PRGF group compared to the HA group after 12 months of treatment (P< 0.001). Conclusion: Besides significantly higher satisfaction belonging to the PRGF group, there was a statistically significant improvement in VAS score and global, pain, and ADL score of Lequesne by passing 12 months from injection in PRGF compared to HA.Keywords
This publication has 66 references indexed in Scilit:
- Treatment With Platelet-Rich Plasma Is More Effective Than Placebo for Knee OsteoarthritisThe American Journal of Sports Medicine, 2013
- Osteoarthritis: A disease of the joint as an organArthritis & Rheumatism, 2012
- A 40-month multicentre, randomised placebo-controlled study to assess the efficacy and carry-over effect of repeated intra-articular injections of hyaluronic acid in knee osteoarthritis: the AMELIA projectAnnals of the Rheumatic Diseases, 2011
- Platelet autologous growth factors decrease the osteochondral regeneration capability of a collagen-hydroxyapatite scaffold in a sheep modelBMC Musculoskeletal Disorders, 2010
- Platelet-Rich Plasma: Where Are We Now and Where Are We Going?Sports Health: A Multidisciplinary Approach, 2010
- Patient Satisfaction after Total Knee Arthroplasty: Who is Satisfied and Who is Not?Clinical Orthopaedics and Related Research, 2010
- Exercise for osteoarthritis of the knee2008
- OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelinesOsteoarthritis and Cartilage, 2008
- Musculoskeletal disorders associated with obesity: a biomechanical perspectiveObesity Reviews, 2006
- Platelet-Rich Plasma (PRP): What Is PRP and What Is Not PRP?Implant Dentistry, 2001